You are here

Large-scale circulating proteome association study (CPAS) meta-analysis identifies circulating proteins and pathways predicting incident hip fractures.

TitleLarge-scale circulating proteome association study (CPAS) meta-analysis identifies circulating proteins and pathways predicting incident hip fractures.
Publication TypeJournal Article
Year of Publication2024
AuthorsAustin, TR, Fink, HA, Jalal, DI, Törnqvist, AE, Bůzková, P, Barzilay, JI, Lu, T, Carbone, L, Gabrielsen, ME, Grahnemo, L, Hveem, K, Jonasson, C, Kizer, JR, Langhammer, A, Mukamal, KJ, Gerszten, RE, Nethander, M, Psaty, BM, Robbins, JA, Sun, YV, Skogholt, AHeidi, Åsvold, BOlav, Valderrábano, RJ, Zheng, J, J Richards, B, Coward, E, Ohlsson, C
JournalJ Bone Miner Res
Date Published2024 Jan 04
ISSN1523-4681
Abstract<p>Hip fractures are associated with significant disability, high cost, and mortality. However, the exact biological mechanisms underlying susceptibility to hip fractures remain incompletely understood. In an exploratory search of the underlying biology as reflected through the circulating proteome, we performed a comprehensive Circulating Proteome Association Study (CPAS) meta-analysis for incident hip fractures. Analyses included 6430 subjects from two prospective cohort studies (Cardiovascular Health Study and Trøndelag Health Study) with circulating proteomics data (aptamer-based 5 K SomaScan version 4.0 assay; 4979 aptamers). Associations between circulating protein levels and incident hip fractures were estimated for each cohort using age and sex-adjusted Cox regression models. Participants experienced 643 incident hip fractures. Compared with the individual studies, inverse-variance weighted meta-analyses yielded more statistically significant associations, identifying 23 aptamers associated with incident hip fractures (conservative Bonferroni correction 0.05/4979, P < 1.0 × 10-5). The aptamers most strongly associated with hip fracture risk corresponded to two proteins of the growth hormone/insulin growth factor system (GHR and IGFBP2), as well as GDF15 and EGFR. High levels of several inflammation-related proteins (CD14, CXCL12, MMP12, ITIH3) were also associated with increased hip fracture risk. Ingenuity pathway analysis identified reduced LXR/RXR activation and increased acute phase response signaling to be overrepresented among those proteins associated with increased hip fracture risk. These analyses identified several circulating proteins and pathways consistently associated with incident hip fractures. These findings underscore the usefulness of the meta-analytic approach for comprehensive CPAS in a similar manner as has previously been observed for large-scale human genetic studies. Future studies should investigate the underlying biology of these potential novel drug targets.</p>
DOI10.1093/jbmr/zjad011
Alternate JournalJ Bone Miner Res
PubMed ID38477735
Grant ListHHSN268201200036C / HL / NHLBI NIH HHS / United States
R01AG023629 / NS / NINDS NIH HHS / United States
/ AG / NIA NIH HHS / United States
ePub date: 
24/03